Search hospitals > Utah > Salt Lake City

University of Utah

Claim this profile
Salt Lake City, Utah 84108
Global Leader in Fibrosis
Global Leader in Heart Failure
Conducts research for Stroke
Conducts research for Syndrome
Conducts research for Muscular Dystrophy
1118 reported clinical trials
138 medical researchers
Photo of University of Utah in Salt Lake CityPhoto of University of Utah in Salt Lake CityPhoto of University of Utah in Salt Lake City

Summary

University of Utah is a medical facility located in Salt Lake City, Utah. This center is recognized for care of Fibrosis, Heart Failure, Stroke, Syndrome, Muscular Dystrophy and other specialties. University of Utah is involved with conducting 1,118 clinical trials across 1,411 conditions. There are 138 research doctors associated with this hospital, such as Benjamin Maughan, MD, Wallace L. Akerley, Torri Metz, MD, and Juan Gallegos-Orozco, MD.

Area of expertise

1Fibrosis
Global Leader
University of Utah has run 76 trials for Fibrosis. Some of their research focus areas include:
rs3570920 TT positive
621+1G->T
CFTR
2Heart Failure
Global Leader
University of Utah has run 68 trials for Heart Failure. Some of their research focus areas include:
BAROSTIM

Top PIs

Clinical Trials running at University of Utah

Stroke
Interstitial Lung Disease
Chronic Kidney Disease
Ulcerative Colitis
Surgical Site Infection
Opioid Use Disorder
Parkinson's Disease
Infections
Bleeding
Kidney Disease
Image of trial facility.

Anti-Coagulant + Anti-Platelet Therapy

for Stroke Prevention

The primary goal of the trial is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm for lowering the 1-year rate of ischemic stroke, intracerebral hemorrhage, or vascular death.
Recruiting2 awards Phase 36 criteria
Image of trial facility.

Thrombectomy + Angioplasty/Stenting

for Stroke

This trial tests if using a stent to open a blocked neck artery along with removing a brain clot is better than just removing the clot alone for stroke patients with severe artery blockages.
Recruiting2 awards Phase 312 criteria
Image of trial facility.

Anticoagulation + Antiplatelet Therapy

for Post-Operative Atrial Fibrillation

The primary objective of this study is to evaluate the effectiveness (prevention of thromboembolic events) and safety (major bleeding) of adding oral anticoagulation (OAC) to background antiplatelet therapy in patients who develop new-onset post-operative atrial fibrillation (POAF) after isolated coronary artery bypass graft (CABG) surgery. All patients with a qualifying POAF event, who decline randomization, will be offered the option of enrollment in a parallel registry that captures their baseline risk profile and their treatment strategy in terms of anticoagulants or antiplatelets received. These patients will also be asked to fill out a brief decliner survey.
Recruiting2 awards Phase 32 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at University of Utah?
University of Utah is a medical facility located in Salt Lake City, Utah. This center is recognized for care of Fibrosis, Heart Failure, Stroke, Syndrome, Muscular Dystrophy and other specialties. University of Utah is involved with conducting 1,118 clinical trials across 1,411 conditions. There are 138 research doctors associated with this hospital, such as Benjamin Maughan, MD, Wallace L. Akerley, Torri Metz, MD, and Juan Gallegos-Orozco, MD.
Where is University of Utah located?
**Directions to University of Utah Hospital, Salt Lake City:** - **By Car:** Take I-15 N and exit at 310B for 400 S. Proceed by turning left onto 500 E, then make a right onto N Campus Dr. - **Public Transit:** The nearest station is U Medical Center Station, which is a 7-minute walk to the hospital.
Who should I call to ask about financial aid or insurance network?
**University of Utah Hospital Financial Assistance and Insurance Information:** - For financial assistance, contact: 801-587-6303 or 800-862-4937. Assistance is based on household income relative to federal guidelines. - Insurance inquiries: Contact the Patient Accounting Department at 801-587-6303 or 800-862-4937. - Accepted insurances at Huntsman Cancer Institute include Aetna, Blue Cross Blue Shield, Cigna, DMBA, PEHP, Select Health, Tricare, United Healthcare (Options PPO), University of Utah Health Plans, Medicare, and Medicaid.
What insurance does University of Utah accept?
The University of Utah Health system accepts a wide range of insurance plans, including most major commercial health plans, traditional Medicare, Utah Medicaid, and many Medicaid HMOs. It is in-network with out-of-state Blue Cross Blue Shield plans that have a suitcase logo on the insurance ID card, indicating BlueCard eligibility. However, ACA/Insurance Marketplace plans, including those from Cigna, are NOT in-network with University of Utah Health facilities and physicians.
What awards or recognition has University of Utah received?
The University of Utah Hospital, located in Salt Lake City, Utah, is renowned for its groundbreaking research and exceptional patient care. It was honored with a $5.4 million Javits Award to support research into migraine origins. Furthermore, neurobiologist Moriel Zelikowsky, Ph.D., was awarded the McKnight Scholar Award for her studies on the effects of social isolation, highlighting the hospital's dedication to medical advancement.